Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Shares Traded Last Trade
  -6.60 -0.4% 1,649.00 4,438,428 14:52:43
Bid Price Offer Price High Price Low Price Open Price
1,649.00 1,649.40 1,684.00 1,647.80 1,666.60
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 30,821.00 4,048.00 73.70 22.4 81,864
Last Trade Time Trade Type Trade Size Trade Price Currency
14:52:41 AT 116 1,649.00 GBX

Glaxosmithkline (GSK) Latest News

More Glaxosmithkline News
Glaxosmithkline Takeover Rumours

Glaxosmithkline (GSK) Share Charts

1 Year Glaxosmithkline Chart

1 Year Glaxosmithkline Chart

1 Month Glaxosmithkline Chart

1 Month Glaxosmithkline Chart

Intraday Glaxosmithkline Chart

Intraday Glaxosmithkline Chart

Glaxosmithkline (GSK) Discussions and Chat

Glaxosmithkline (GSK) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
13:52:411,649.001161,912.84AT
13:52:391,649.201442,374.85AT
13:52:391,649.201802,968.56AT
13:52:281,649.031,83230,210.22O
13:52:241,649.202003,298.40AT
View all Glaxosmithkline trades in real-time

Glaxosmithkline (GSK) Top Chat Posts

DateSubject
16/10/2019
09:20
Glaxosmithkline Daily Update: Glaxosmithkline Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker GSK. The last closing price for Glaxosmithkline was 1,655.60p.
Glaxosmithkline Plc has a 4 week average price of 1,612.40p and a 12 week average price of 1,612.40p.
The 1 year high share price is 1,767p while the 1 year low share price is currently 1,408.80p.
There are currently 4,964,461,674 shares in issue and the average daily traded volume is 9,994,802 shares. The market capitalisation of Glaxosmithkline Plc is £81,873,901,927.61.
08/10/2019
17:53
jubberjim: Withdrawal of zantac due to carcinigenic ingredient Would think will adversely affect share price But from past experience the bots are in control with neither logic or reason entering into their programme so will watch from sidelines for time being Be very careful
05/8/2019
07:02
sogoesit: TM’ comment: “Its not necessarily a given that merging out/selling 0ff/floating off-patent products/generic products/non-prescription products ('consumer healthcare') will unlock value ('sum of the parts' theory) and boost the prorated share price of a big pharmaceutical company.” Agreed that this is not “a given”. What is? But there is a chance and we make our guesses as to that probability. Restructuring does, in general, throw up opportunities. What they are is difficult to foretell. In the same way that M&A generally fails the reverse may be true. At least we will get price discovery, positively or negatively, and a fairer view of the price of the parts. Good luck either way. AIMV
02/8/2019
13:32
tradermichael: Its not necessarily a given that merging out/selling 0ff/floating off-patent products/generic products/non-prescription products ('consumer healthcare') will unlock value ('sum of the parts' theory) and boost the prorated share price of a big pharmaceutical company. Take a look at Pfizer. After closing Friday at more than $43, Pfizer shares have since dropped to the $38 range after sealing a merger of its off-patent drugs business with Mylan. Without its consumer health business and its established products unit, Pfizer will be doubling down on branded prescription drugs. And in their remaining division, “both revenue and EPS growth will be higher" while the size of the top line itself — and earnings figures, too — will shrink. Time will tell, but watch that outcome with GSK in mind ………; ;0)
19/12/2018
16:33
wbecki: WOW in space of 7 minutes GSK share price worth 75p less!!!! What changed? Or was it a typo? montyhedge 19 Dec '18 - 11:23 - 18655 of 18691 Looked more into it, GSK great deal 1750p here we come. Walsmley on CNBC 30 minutes time, first interview. 80p dividend at least for 2019, then looks like could be increased, yippee. This deal is the transforming deal GSK been looking for. montyhedge 19 Dec '18 - 11:30 - 18656 of 18691 1675p here we come, I reckon, Walsmley CNBC 12pm London time, 7am New York time, first interview. Should create a lot of buying interest.
06/12/2018
09:30
anhar: In December 2000, two of the UK's largest pharmaceutical companies, Glaxo Wellcome and SmithKline Beecham came together to form global giant GlaxoSmithKline. At that time, GSK's share price was close to £21, valuing the firm at close to £110bn and putting it in the top three of the FTSE 100. Fast forward almost 18 years and GSK's share price is around £14.75, or about a third lower than at the time of the merger. That’s a bitter pill to swallow for investors as the deal has failed to prevent the destroyal of roughly £30bn of shareholder wealth. TM: Most will be aware of this appalling long term capital performance by GSK. The mystery is why you think it's the one share in which to invest so much, with that history. This is not a new thing, it's been clear for many years that GSK is an awful share for capital gain purposes. I invest only for income and have held for a long time now during which it has done what I wanted on dividends, up to a point though even that's been frozen for years now, but if I was a capital player and willing to risk it all or most on just one stock, I would never consider GSK. They are proven losers, at least over the last 18 years. Long term my dividend stocks have in total done very well on capital, though that's not why I invest this way, but GSK is one of the exceptions. In fact with the market fall pushing up the FTSE100 yield, and GSK's frozen 80p dividend making a yield of 5.6% at 1435p, it's getting closer to my exit point.
23/11/2018
16:40
barbel3: hi guys so if the dollar drops to the pound does that mean its better for gsk share price just out of interest cheers
02/11/2018
14:05
jadeticl3: What was it that caused the GSK share price to leap 50p on the day of the results announcement, but then fall by 90p. And then by more thereafter?
02/10/2018
08:37
mr woodentop: Blimey - sounds like the daily express yesterday with 'pound goes ballistic'. It was up 0.3%. Today it is down by about the same amount. The GSK share price, although affected by the £ should not be totally dependent on it. The BOD's actions should be making it rise over the mid to long term. Jury is still out on that one though! keep taking the divis
04/11/2017
08:11
tradermichael: 20 years ago, in September 1997, the GSK share price rose from today's price to 2068p one year later ........
01/7/2017
08:26
tradermichael: m_k_hubbert - yes, and for my trades at £150K, I factor in a 7.5p increase in GSK share price is required for my costs to break even. ..... ;0)
Glaxosmithkline share price data is direct from the London Stock Exchange
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191016 14:07:47